SAGINAW, MI--(Marketwired - Jan 22, 2015) -  HPIL Holding (the "Company" or "HPIL") (OTCQB: HPIL) is pleased to announce that its wholly owned subsidiary HPIL HEALTHCARE Inc., on January 15, 2015, entered into a Cooperation Agreement (the "Agreement") with COEUS TECHNOLOGY Inc., a Indiana (USA) private manufacturing, research and development company specializing in antimicrobial nano technologies, and focused in the healthcare and environmental sectors. Under the Agreement, the parties intend to work cooperatively to develop and expand projects between the parties beginning January 15, 2015. The term of the Agreement is one year unless terminated earlier by either party. For more information regarding HPIL Holding, please visit its website at www.hpilholding.com. For more information regarding HPIL HEALTHCARE Inc., please visit its website at www.hpilhealthcare.com. For more information regarding COEUS TECHNOLOGY Inc., please visit its website at www.coeustechnology.com.

Mr. Louis Bertoli, President and CEO of HPIL Holding, said he was "very pleased to be working closely with COEUS TECHNOLOGY Inc. through HPIL's wholly owned subsidiary HPIL HEALTHCARE Inc."

Mr. Nate Richardson, President and Managing Partner of COEUS TECHNOLOGY Inc., said, "We are looking forward to develop for our products the market sectors that HPIL HEALTHCARE is focused on. This should widen our international footprint."

Mr. Nitin Amersey, CFO and Director of HPIL Holding, said, "This is an exciting development for HPIL's wholly owned subsidiary HPIL HEALTHCARE Inc. related to COEUS TECHNOLOGY Inc.'s product range." 

Safe Harbor:

This news release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when used in the preceding discussion, the words "pleased," "plan," "confident that," "believe," "expect," or "intend to," and similar conditional expressions are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the Company's products and technologies, competitive factors, the ability to successfully complete additional financings and other risks described in the Company's SEC reports and filings.